PepGen Inc.
World Rank (Jan-05-2024)
18,296
Market Cap (Jan-05-2024)
0.186 Billion USD
World Rank (Jul-30-2023)
19,669
Market Cap (Jul-30-2023)
0.147 Billion USD
World Rank (Dec-25-2022)
14,653
Market Cap (Dec-25-2022)
0.355 Billion USD
World Rank (Jan-07-2022)
18,400
Company Profile
PepGen Inc is a clinical stage biotechnology company focused on advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. The headquarters is in Massachusetts.
Company Website